Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02766374 · ClinicalTrials.gov registry record · NA

Heart Rate Variability Biofeedback: It's Role in Asthma Therapeutics

A NA study of Asthma, sponsored by Fred Wamboldt, MD.

Completed
Registry status
NA
Development phase
68
Enrollment target
2
Study locations

NCT02766374: Completed NA study of Asthma, sponsored by Fred Wamboldt, MD.

NCT02766374 is a NA study of Asthma that has completed, run by Fred Wamboldt, MD. The registered enrollment target is 68 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02766374, a NA study of Asthma, has completed, sponsored by Fred Wamboldt, MD.

COMPLETED
Registry status
NA
Development phase
68 participants
Enrollment target
2
Study locations

Study Summary

The goal of this research study to see whether biofeedback therapy helps treat asthma, and if so, how it works. Biofeedback is a treatment method that can teach how to bodily control. Biofeedback is widely used to help people relax. In this study however, the investigators want to learn if a specific type of biofeedback actually improves asthma in a way that might allow the reduction or elimination of other controller treatments like inhaled-corticosteroids.

Conditions Studied

Interventions

  • BEHAVIORAL Placebo
  • BEHAVIORAL Heart rate variability biofeedback

Study Locations (2)

Colorado

  • National Jewish Health - Denver

New Jersey

  • Rutgers Robert Wood Johnson Medical School - Piscataway

Trial Details

FieldValue
Enrollment Target 68 participants
Start Date 2009-12
Est. Completion 2018-01
Phase NA

Sponsor

Fred Wamboldt, MD

1 total trials

What the Registry Record Tells You About NCT02766374

The ClinicalTrials.gov registry entry for NCT02766374 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (96% lower). The listed sponsor is Fred Wamboldt, MD, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT02766374 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Colorado, New Jersey.

Frequently Asked Questions

What is clinical trial NCT02766374 about?

NCT02766374 is a clinical study titled "Heart Rate Variability Biofeedback: It's Role in Asthma Therapeutics". The goal of this research study to see whether biofeedback therapy helps treat asthma, and if so, how it works. Biofeedback is a treatment method that can teach how to bodily control. Biofeedback is widely used to help people relax. In this study however, the investigators want to learn if a specifi...

What is the current status of trial NCT02766374?

This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2009-12. Estimated completion is 2018-01.

What conditions does trial NCT02766374 study?

This clinical trial studies the following conditions: Asthma.

What interventions are being tested in trial NCT02766374?

The interventions under investigation include: Placebo (BEHAVIORAL), Heart rate variability biofeedback (BEHAVIORAL).

Who is sponsoring clinical trial NCT02766374?

This trial is sponsored by Fred Wamboldt, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02766374 being conducted?

This trial has 2 study locations across Colorado, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.